HRC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HRC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Hill-Rom Holdings's PE Ratio without NRI is 41.92. Hill-Rom Holdings's 5-Year EBITDA growth rate is 4.60%. Therefore, Hill-Rom Holdings's PEG Ratio for today is 9.11.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Hill-Rom Holdings's PEG Ratio or its related term are showing as below:
During the past 13 years, Hill-Rom Holdings's highest PEG Ratio was 54.24. The lowest was 1.41. And the median was 2.62.
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
The historical data trend for Hill-Rom Holdings's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hill-Rom Holdings Annual Data | |||||||||||||||||||||
Trend | Sep12 | Sep13 | Sep14 | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | |||||||||||
PEG Ratio | Get a 7-Day Free Trial | 3.89 | 1.60 | 2.60 | 1.91 | 8.35 |
Hill-Rom Holdings Quarterly Data | ||||||||||||||||||||
Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | |
PEG Ratio | Get a 7-Day Free Trial | 1.91 | 2.56 | 3.00 | 4.95 | 8.35 |
For the Medical Instruments & Supplies subindustry, Hill-Rom Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Hill-Rom Holdings's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Hill-Rom Holdings's PEG Ratio falls into.
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.
Hill-Rom Holdings's PEG Ratio for today is calculated as
PEG Ratio | = | PE Ratio without NRI | / | 5-Year EBITDA Growth Rate* |
= | 41.924731182796 | / | 4.60 | |
= | 9.11 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Hill-Rom Holdings (NYSE:HRC) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Thank you for viewing the detailed overview of Hill-Rom Holdings's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Mary Kay Ladone | officer: SVP, Corp. Dev., Strat. & IR | 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601 |
Deborah Rasin | officer: SVP, Chief Legal Officer | TWO PRUDENTIAL PLAZA, SUITE 4100, CHICAGO IL 60601 |
Paul Sherwood Johnson | officer: SVP & Pres. - PSS Acute Care | TWO PRUDENTIAL PLAZA 180 NORTH STETSON AVENUE, SUITE 4100 CHICAGO IL 60601 |
Andreas G Frank | officer: SVP, Pres. Front Line Care | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Richard M Wagner | officer: Corporate Controller | 221 WEST PHILADELPHIA STREET, SUITE 60W, YORK PA 17401-2991 |
Amy M. Dodrill | officer: President - Surgical Solutions | 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601 |
Gary Lee Ellis | director | THE TORO COMPANY, 8111 LYNDALE AVENUE SOUTH, BLOOMINGTON MN 55420 |
Mary Garrett | director | ETHAN ALLEN DRIVE, DANBURY CT 06811 |
Gregory J. Moore | director | 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601 |
William Kucheman | director | C/O DAN DUGAN, FINANCIAL PERSPECTIVES, 3025 HARBOR LN., SUITE 200, PLYMOUTH MN 55447 |
James R Giertz | director | |
Ronald A Malone | director | 3 HUNTINGTON QUADRANGLE, SUITE 200S, MELVILLE NY 11747 |
Felicia F Norwood | director | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
William G Dempsey | director | C/O LANDAUER, INC., 2 SCIENCE ROAD, GLENWOOD IL 60425 |
Nancy M Schlichting | director | 200 WILMOT ROAD, DEERFIELD IL 60015 |
From GuruFocus
By PRNewswire PRNewswire • 04-21-2021
By Marketwired Marketwired • 09-09-2021
By Don Li2 Don Li2 • 11-08-2021
By GF Value GF Value • 03-31-2021
By PRNewswire PRNewswire • 03-11-2021
By Business Wire Business Wire • 09-07-2021
By PRNewswire PRNewswire • 05-10-2021
By GF Value GF Value • 05-19-2021
By Marketwired Marketwired • 10-06-2021
By GuruFocus Research GuruFocus Editor • 08-23-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.